Hims & Hers (HIMS) Investors Pulling Their Hair Out Over Pills Side-Effects
Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...
The FDA Cracking Down on Compounded Weight Loss Drugs – Here’s What It Means for Telehealth Companies and Consumers
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Marketing winners and losers of the week
Paramount Pictures made a savvy plug for “Novocaine,” and Dick’s Sporting Goods was a “magnet” for holiday shoppers—plus, why ...
11 creative campaigns to know about today
Among today’s creative highlights, Clorox brought in neuroscientists to demonstrate some surprising data about how cleaning ...
BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail
The newly acquired ELITech Molecular Diagnostics business also contributed, positioning Bruker as an emerging infectious disease specialist in the in-vitro diagnostics (IVD) market. Within Bruker’s ...
Millions of people are taking compounded weight loss drugs. Now they're about to disappear.
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...